Capecitabine (Cape) versus 5-fluorouracil (5-FU)–based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial.

Hofheinz, R. ; Wenz, F. K. ; Post, S. ; Matzdorff, A. ; Laechelt, S. ; Hartmann, J. T. ; Müller, L. ; Link, H. ; Moehler, M. H. ; Kettner, E. ; Fritz, E. ; Hieber, U. ; Lindemann, H. W. ; Grunewald, M. ; Kremers, S. ; Constantin, C. ; Hipp, M. ; Gencer, D. ; Burkholder, I. ; Hochhaus, A.

Alternative links to fulltext:DOI Publisher